MB
MPM BioImpact Portfolio holdings
AUM
$577M
This Quarter Return
+37.26%
1 Year Return
+8.33%
3 Year Return
+241.63%
5 Year Return
+127.38%
10 Year Return
–
AUM
$569M
AUM Growth
+$569M
(+37%)
Cap. Flow
+$71.2M
Cap. Flow
% of AUM
12.5%
Top 10 Holdings %
Top 10 Hldgs %
94.85%
Holding
13
New
1
Increased
–
Reduced
1
Closed
–
Top Buys
| 1 |
ONCR
Oncorus, Inc.
ONCR
|
$76.8M |
Top Sells
| 1 |
EPZM
Epizyme, Inc
EPZM
|
$5.68M |
Sector Composition
| 1 | Healthcare | 95.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TCRR
1
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $104M | 18.31% | 3,370,982 | – | – |
|
2
Repare Therapeutics
RPTX
$71.7M
| $81.9M | 14.39% | 2,388,337 | – | – |
|
3
iTeos Therapeutics
ITOS
| $79.7M | 13.99% | 2,355,557 | – | – |
|
|
ONCR
4
DELISTED
Oncorus, Inc.
ONCR
| $76.8M | 13.5% | +2,377,031 | New | +$76.8M |
|
|
HARP
5
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $64.8M | 11.37% | 3,898,422 | – | – |
|
|
TPTX
6
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $37.6M | 6.61% | 308,686 | – | – |
|
|
GTHX
7
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $25.6M | 4.5% | 1,423,794 | – | – |
|
|
EPZM
8
DELISTED
Epizyme, Inc
EPZM
| $25.3M | 4.45% | 2,331,534 -523,203 | -18% | -$5.68M |
|
9
ADC Therapeutics
ADCT
$345M
| $17.3M | 3.03% | 539,648 | – | – |
|
10
Y-mAbs Therapeutics
YMAB
$388M
| $16.7M | 2.93% | 337,291 | – | – |
|
11
Merus
MRUS
$4.98B
| $12.3M | 2.16% | 700,879 | – | – |
|
|
AUTL
12
Autolus Therapeutics
AUTL
$399M
| $355K | 0.06% | 39,740 | – | – |
|